Stock CQCIL CIPLA QUALITY CHEMICAL INDUSTRIES LTD
Add to a list
To use this feature you must be a member
Log inSign up

Financials Cipla Quality Chemical Industries Ltd

Equities

CQCIL

UG0000000196

End-of-day quote UGANDA SECURITIES EXCHANGE
Other stock markets
- UGX - Intraday chart for Cipla Quality Chemical Industries Ltd
2023 Africa Capitalworks SSA 3 completed the acquisition of 51.18% stake in Cipla Quality Chemical Industries Limited from Cipla (EU) Limited and Meditab Holdings Ltd. for $25 million. CI
2023 Cipla Quality Chemical Industries Limited Reports Earnings Results for the Full Year Ended March 31, 2023 CI

Valuation

Fiscal Period: March 2019 2020 2021 2022 2023
Capitalization 1 693,863 372,495 346,931 325,020 219,115
Enterprise Value (EV) 1 745,067 416,191 372,973 342,538 213,820
P/E ratio 102 x -16.1 x -32.9 x 13.5 x 11.5 x
Yield - - - 2.25% 4.17%
Capitalization / Revenue 3.56 x 1.93 x 1.22 x 1.22 x 0.99 x
EV / Revenue 3.82 x 2.16 x 1.31 x 1.28 x 0.97 x
EV / EBITDA 37.2 x 56.1 x 31.8 x 7.13 x 5.61 x
EV / FCF -12.8 x 9.83 x 13 x 146 x 9.57 x
FCF Yield -7.8% 10.2% 7.68% 0.68% 10.5%
Price to Book 4.12 x 2.56 x 2.56 x 2.03 x 1.28 x
Nbr of stocks (in thousands) 3,651,909 3,651,909 3,651,909 3,651,909 3,651,909
Reference price 2 190.0 102.0 95.00 89.00 60.00
Announcement Date 7/5/19 6/17/20 8/30/21 7/27/22 6/13/23
1UGX in Million2UGX
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net sales 1 227,315 195,136 192,682 284,540 267,432 221,466
EBITDA 1 49,121 20,013 7,420 11,735 48,066 38,110
EBIT 1 42,729 15,134 1,211 3,778 39,652 29,015
Operating Margin 18.8% 7.76% 0.63% 1.33% 14.83% 13.1%
Earnings before Tax (EBT) 1 43,993 7,128 -35,732 -9,694 37,774 31,783
Net income 1 44,627 6,786 -23,073 -10,538 24,051 18,987
Net margin 19.63% 3.48% -11.97% -3.7% 8.99% 8.57%
EPS 2 12.22 1.858 -6.318 -2.886 6.586 5.199
Free Cash Flow 1 1,100 -58,109 42,351 28,662 2,339 22,345
FCF margin 0.48% -29.78% 21.98% 10.07% 0.87% 10.09%
FCF Conversion (EBITDA) 2.24% - 570.76% 244.25% 4.87% 58.63%
FCF Conversion (Net income) 2.46% - - - 9.72% 117.69%
Dividend per Share 2 3.040 - - - 2.000 2.500
Announcement Date 8/10/18 7/5/19 6/17/20 8/30/21 7/27/22 6/13/23
1UGX in Million2UGX
Estimates

Balance Sheet Analysis

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt 1 - 51,205 43,696 26,041 17,518 -
Net Cash position 1 21,636 - - - - 5,295
Leverage (Debt/EBITDA) - 2.559 x 5.889 x 2.219 x 0.3645 x -
Free Cash Flow 1 1,100 -58,109 42,351 28,662 2,339 22,345
ROE (net income / shareholders' equity) 28.4% 3.96% -14.7% -7.5% 16.3% 11.5%
ROA (Net income/ Total Assets) 14.1% 3.81% 0.28% 0.99% 10.5% 7.88%
Assets 1 315,753 178,220 -8,173,171 -1,059,226 228,496 240,893
Book Value Per Share 2 47.70 46.10 39.80 37.20 43.70 46.90
Cash Flow per Share 2 2.890 0.2000 1.120 2.480 2.320 2.960
Capex 1 26,068 10,529 14,815 6,199 7,503 10,897
Capex / Sales 11.47% 5.4% 7.69% 2.18% 2.81% 4.92%
Announcement Date 8/10/18 7/5/19 6/17/20 8/30/21 7/27/22 6/13/23
1UGX in Million2UGX
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. CQCIL Stock
  4. Financials Cipla Quality Chemical Industries Ltd